Status:
COMPLETED
Comparison of Postoperative Pain Application of Alfentanil or Remifentanil in TIVA
Lead Sponsor:
Xijing Hospital
Conditions:
Postoperative Pain
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Total intravenous anesthesia (TIVA) is maintained by intermittent or continuous combined intravenous injection of a variety of short-acting intravenous anesthetics, which can provide safe and rapid in...
Detailed Description
This study intends to observe the effect of TIVA using afentanil or remifentanil on postoperative pain in patients undergoing functional nasal endoscopic surgery under general anesthesia. Main indica...
Eligibility Criteria
Inclusion
- Age 18-65 years old
- ASA Ⅰ-Ⅲ
- patients undergoing functional endoscopic sinus surgery under general anesthesia.
Exclusion
- Significant hypertension (diastolic blood pressure \> 100mmHg) or hypotension (systolic . blood pressure \< 100mmHg).
- severe mental, cardiovascular, kidney or liver disease.
- previous history of alcohol or drug abuse.
- long-term use of painkillers before operation.
- contraindications for any drugs used in the study.
Key Trial Info
Start Date :
April 29 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2022
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT05344911
Start Date
April 29 2022
End Date
August 30 2022
Last Update
January 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
YANLI
XIan, Shanxi, China, 710032